InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF) Files Provisional Patent for Pain Program
InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF), has more major news today as they have filed a provisional patent for pain program. This is a huge step in protecting intellectual and commercial property related to their groundbreaking research into the potential of non-THC cannabinoids to treat pain using a topical formulation..
Demand Outpacing Supply as Canadian Cannabis Legalization Looms
The Canadian government's plan to push through legalization of marijuana for recreational purposes by mid-2018 figures to deal a serious blow to the existing black market. ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) is poised to capitalize.
Supreme Pharmaceuticals Inc. (TSXV: FIRE) announces that 7ACRES' first month of sales exceeded $1,500,000, and that such sales will be recorded in the quarter ended September 30, 2017.
This news release/advertorial is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in small-cap and micro-cap securities is highly speculative and carries an extremely high degree of risk. This website makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Compensation: A thirty-six-thousand-dollar investor relations budget is being managed by The Seed Investor. Any funds leftover after expenses for research, overhead, advertising and public relations related to InMed Pharmaceuticals Inc. (ticker symbol (CSE: IN; OTCQB: IMLFF) will be considered profit. The Seed Investor and/or entities related to The Seed Investor hold shares in (CSE: IN; OTCQB: IMLFF) and intend to sell those shares. Please review all investment decisions with a licensed investment advisor.
TheSeedInvestor.com 9375 E Shea Blvd Ste 100
Scottsdale 85260
